Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.

Afdhal, Nezam

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. [electronic resource] - The New England journal of medicine May 2014 - 1889-98 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1533-4406

10.1056/NEJMoa1402454 doi


Adolescent
Adult
Aged
Aged, 80 and over
Antiviral Agents--adverse effects
Benzimidazoles--adverse effects
Drug Administration Schedule
Drug Resistance, Viral
Drug Therapy, Combination
Female
Fluorenes--adverse effects
Genotype
Hepacivirus--genetics
Hepatitis C, Chronic--drug therapy
Humans
Male
Middle Aged
RNA, Viral--blood
Ribavirin--adverse effects
Sofosbuvir
Uridine Monophosphate--adverse effects
Viral Load
Young Adult